Octapharma

We are performing scheduled maintenance on Tuesday, September 22 between 1:00 and 1:30am EDT. We appreciate your patience as we improve your experience!

About us

Our passion drives us to provide new health solutions advancing human life.

Learn about Octapharma

News & Stories

Our latest news from Canada and around the world

09/01/2026

Press release

Health Canada approves new cardiac-surgery indication for Octaplex®, based on evidence generated in Canada

03/29/2025

Press release

JAMA Publishes Groundbreaking FARES-II Study Confirming the Superior Hemostatic Efficacy of Octaplex® (4F-PCC) Over Frozen Plasma in Cardiac Surgery

08/22/2024

Press release

Canadian Study Reveals New Approach to Managing Bleeding Risks in Patients on FXa Inhibitors with the prophylactic use of octaplex® During Emergency Surgery

05/22/2024

Press release

Wilate® is now approved in Canada for Prophylaxis in Von Willebrand Disease

SHOW ALL NEWS

Careers in Canada

Explore a new world of opportunities

When you choose to gives us your talent, you become a member of our family. From researching and developing therapies to helping people live near normal lives, your talent can help us achieve more, working together and learning from each other.

Working with Octapharma

About us

Our latest news from Canada and around the world

Health Canada approves new cardiac-surgery indication for Octaplex®, based on evidence generated in Canada

JAMA Publishes Groundbreaking FARES-II Study Confirming the Superior Hemostatic Efficacy of Octaplex® (4F-PCC) Over Frozen Plasma in Cardiac Surgery

Canadian Study Reveals New Approach to Managing Bleeding Risks in Patients on FXa Inhibitors with the prophylactic use of octaplex® During Emergency Surgery

Wilate® is now approved in Canada for Prophylaxis in Von Willebrand Disease

Explore a new world of opportunities

About us

Plasma

Therapies

Careers

News